Rx HealthCare Services

Rx HealthCare Services understands that there is no place like home. We also know that there may come a time when you or a loved one is in need of additional nursing or a caregivers help in order to stay at home. That’s where we can lend a helping hand. We provide Home Health, Hospice, Behavioral Health, Care giving and Case Management. We have been providing care and services throughout the Sacramento Region since 1991.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

AVENUEB CREATES A PATH TO SUCCESS FOR BIOLOGY STUDENTS

UC Davis | April 14, 2020

news image

The Genentech Foundation has donated $2.5 million to the University of California, Davis, College of Biological Sciences — the college’s largest single gift ever — to fund a program that will help biology students transferring from community college. Called AvenueB, the program will provide financial support and preparatory programs for students going to four-year university. According to the Campaign for College Opportunity, students transferring from community colleges to a U...

Read More

INDUSTRY OUTLOOK

REGENERX LICENSEE ACQUIRED BY KOREAN BIOPHARMACEUTICAL GROUP

RegeneRx Biopharmaceuticals, Inc. | September 28, 2021

news image

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration), announced that GtreeBNT, the licensee for several RegeneRx products, is being acquired by HLB Group, a Korean company that includes six biopharmaceutical and financial subsidiaries in Korea and the U.S. GtreeBNT announced that as part of its acquisition the company would issue approximately US$80 million of new stock and convertible bonds to HLB Grou...

Read More

CELL AND GENE THERAPY

GRACELL BIOTECHNOLOGIES UNVEILS INNOVATION CENTER IN U.S.

Gracell Biotechnologies Inc | January 13, 2022

news image

Gracell Biotechnologies Inc. a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that its newly established research facility, the Innovation Center, is scheduled to open in San Diego, California, during the first quarter of 2022. As a pivotal part of Gracell's global strategy, the company is fully committed to expanding its operations in the U.S. to enhance and ...

Read More

RESEARCH

BIO-TECHNE AND CARTERRA INITIATE A CLINICAL RESEARCH COLLABORATION FOR COVID-19 VARIANT ANALYSIS

Bio-Techne Corporation | September 08, 2021

news image

Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, today announced a clinical research collaboration studying COVID-19 variants. New variants, such as Delta, can be more easily transmitted and more likely to evade the immune response of vaccinated or previously infected people. To assess immune responses to ...

Read More
news image

AVENUEB CREATES A PATH TO SUCCESS FOR BIOLOGY STUDENTS

UC Davis | April 14, 2020

The Genentech Foundation has donated $2.5 million to the University of California, Davis, College of Biological Sciences — the college’s largest single gift ever — to fund a program that will help biology students transferring from community college. Called AvenueB, the program will provide financial support and preparatory programs for students going to four-year university. According to the Campaign for College Opportunity, students transferring from community colleges to a U...

Read More
news image

INDUSTRY OUTLOOK

REGENERX LICENSEE ACQUIRED BY KOREAN BIOPHARMACEUTICAL GROUP

RegeneRx Biopharmaceuticals, Inc. | September 28, 2021

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration), announced that GtreeBNT, the licensee for several RegeneRx products, is being acquired by HLB Group, a Korean company that includes six biopharmaceutical and financial subsidiaries in Korea and the U.S. GtreeBNT announced that as part of its acquisition the company would issue approximately US$80 million of new stock and convertible bonds to HLB Grou...

Read More
news image

CELL AND GENE THERAPY

GRACELL BIOTECHNOLOGIES UNVEILS INNOVATION CENTER IN U.S.

Gracell Biotechnologies Inc | January 13, 2022

Gracell Biotechnologies Inc. a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that its newly established research facility, the Innovation Center, is scheduled to open in San Diego, California, during the first quarter of 2022. As a pivotal part of Gracell's global strategy, the company is fully committed to expanding its operations in the U.S. to enhance and ...

Read More
news image

RESEARCH

BIO-TECHNE AND CARTERRA INITIATE A CLINICAL RESEARCH COLLABORATION FOR COVID-19 VARIANT ANALYSIS

Bio-Techne Corporation | September 08, 2021

Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in high-throughput antibody screening and characterization, today announced a clinical research collaboration studying COVID-19 variants. New variants, such as Delta, can be more easily transmitted and more likely to evade the immune response of vaccinated or previously infected people. To assess immune responses to ...

Read More